Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q4 2025 Earnings Call Transcript
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q4 2025 Earnings Call Transcript February 27, 2026Treace Medical Concepts, Inc. beats earnings expectations.
Treace Medical Concepts Inc. (TMCI)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Armistice Capital Steven Boyd | 6,364,000 | $25,328,720 | 0.31% | |
| 2. | AQR Capital Management Cliff Asness | 1,497,673 | $5,960,738 | +42% | 0% |
| 3. | Marshall Wace LLP Paul Marshall And Ian Wace | 1,328,592 | $5,287,797 | +402% | 0% |
| 4. | Millennium Management Israel Englander | 738,628 | $2,939,739 | -36% | 0% |
| 5. | D E Shaw D. E. Shaw | 583,277 | $2,321,442 | -31% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.34 | 11,000 | $47,731.20 | 7,404,383 | 2026-08-24 | Filing | |
| $4.35 | 5,000 | $21,747.50 | 7,393,383 | 2026-08-21 | Filing | |
| $4.44 | 39,944 | $177,175.61 | 7,388,383 | 2026-08-20 | Filing | |
| $4.04 | 9,891 | $39,982.39 | 7,348,439 | 2026-06-11 | Filing | |
| $4.02 | 14,715 | $59,213.16 | 7,338,548 | 2026-06-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.97 | 50,000 | $398,460.00 | 364,081 | 2025-03-17 | Filing | |
| $24.02 | 1,700 | $40,828.39 | 1,036,441 | 2022-11-15 | Filing | |
| $21.97 | 200 | $4,394.00 | 1,038,141 | 2022-11-15 | Filing | |
| $21.18 | 1,600 | $33,890.08 | 1,038,341 | 2022-11-15 | Filing | |
| $20.12 | 46,500 | $935,580.00 | 1,039,941 | 2022-11-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,305,100 | $13,154,298 | 0% | |
| 2. | 3,029,543 | $12,057,581 | 2.32% | |
| 3. | 2,028,479 | $8,073,346 | 0% | |
| 4. | 1,534,034 | $6,105,455 | 3.88% | |
| 5. | 1,380,021 | $5,492,483 | 0% |
News See All
Stifel Revises Treace Medical Concepts, Inc. (TMCI) Price Target in Sector-Wide Update
We recently published an article titled 11 High Growth Micro-cap Stocks to Buy. Treace Medical Concepts is one of the high-growth micro-cap stocks to buy.
11 High Growth Micro-cap Stocks to Buy
In this article, we will discuss 11 High Growth Micro-cap Stocks to Buy.
10 Best Biotech Penny Stocks to Buy According to Analysts
On December 24, Jared Holz of Mizuho joined 'Power Lunch' on CNBC to talk about how to play biotech moving into 2026.
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q3 2025 Earnings Call Transcript
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q3 2025 Earnings Call Transcript November 7, 2025 Trip Taylor: Good afternoon, everyone, and welcome to our third quarter 2025 earnings conference call.
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q2 2025 Earnings Call Transcript
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q2 2025 Earnings Call Transcript August 8, 2025 Operator: Good day, and thank you for standing by.
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q1 2025 Earnings Call Transcript
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q1 2025 Earnings Call Transcript May 8, 2025Treace Medical Concepts, Inc. beats earnings expectations. Reported EPS is $-0.25, expectations were $-0.31.
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q4 2024 Earnings Call Transcript
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q4 2024 Earnings Call Transcript February 28, 2025 Operator: Welcome to the Treace Medical Concepts Fourth Quarter 2024 Earnings Conference Call.
Why Treace Medical Concepts (TMCI) Is Rallying Today
Treace Medical Concepts (TMCI) is jumping 7.5% after investment bank BTIG upgraded the shares to Buy from Neutral.
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q3 2024 Earnings Call Transcript
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q3 2024 Earnings Call Transcript November 5, 2024Treace Medical Concepts, Inc. beats earnings expectations.
Hedge Fund Resource Center